Research teams saw a significant number of SARS-CoV-2 infections during an aircraft carrier outbreak and in Marine recruits undergoing strict quarantine.
The firm presented data at the European Society for Medical Oncology Virtual Congress last weekend showing how its method could identify signs of early-stage cancers.
The firm said its coronavirus assay targets the nucleocapsid and envelope virus genes and is compatible with most RNA extraction methods and qPCR instruments.
Using exome-enriched RNA sequencing and machine learning, researchers tracked down a set of circulating maternal transcripts for predicting severe early-onset preeclampsia.
Roche will have non-exclusive access to SpeeDx's existing tests and technology to enable expansion of diagnostic products for antibiotic resistance in STIs.
The test detects SARS-CoV-2 from nasopharyngeal swab specimens and runs on standard qPCR instruments, including Thermo Fisher's Applied Biosystems 7500 Fast machine.
